ID   CH3L1_HUMAN             Reviewed;         383 AA.
AC   P36222; B2R7B0; P30923; Q8IVA4; Q96HI7;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   20-DEC-2005, sequence version 2.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Chitinase-3-like protein 1;
DE   AltName: Full=39 kDa synovial protein;
DE   AltName: Full=Cartilage glycoprotein 39;
DE            Short=CGP-39;
DE            Short=GP-39;
DE            Short=hCGP-39;
DE   AltName: Full=YKL-40;
DE   Flags: Precursor;
GN   Name=CHI3L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, AND VARIANT
RP   THR-311.
RC   TISSUE=Cartilage;
RX   PubMed=8245017;
RA   Hakala B.E., White C., Recklies A.D.;
RT   "Human cartilage gp-39, a major secretory product of articular
RT   chondrocytes and synovial cells, is a mammalian member of a chitinase
RT   protein family.";
RL   J. Biol. Chem. 268:25803-25810(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT THR-311.
RC   TISSUE=Blood;
RX   PubMed=9244440; DOI=10.1006/geno.1997.4778;
RA   Rehli M., Krause S.W., Andressen R.;
RT   "Molecular characterization of the gene for human cartilage gp-39
RT   (CHI3L1), a member of the chitinase protein family and marker for late
RT   stages of macrophage differentiation.";
RL   Genomics 43:221-225(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-145.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-145.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 22-45.
RX   PubMed=2375755; DOI=10.1042/bj2690265;
RA   Nyirkos P., Golds E.E.;
RT   "Human synovial cells secrete a 39 kDa protein similar to a bovine
RT   mammary protein expressed during the non-lactating period.";
RL   Biochem. J. 269:265-268(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=9492324; DOI=10.1046/j.1432-1327.1998.2510504.x;
RA   Renkema G.H., Boot R.G., Au F.L., Donker-Koopman W.E., Strijland A.,
RA   Muijsers A.O., Hrebicek M., Aerts J.M.F.G.;
RT   "Chitotriosidase, a chitinase, and the 39-kDa human cartilage
RT   glycoprotein, a chitin-binding lectin, are homologues of family 18
RT   glycosyl hydrolases secreted by human macrophages.";
RL   Eur. J. Biochem. 251:504-509(1998).
RN   [9]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=16472595; DOI=10.1053/j.gastro.2005.12.007;
RA   Mizoguchi E.;
RT   "Chitinase 3-like-1 exacerbates intestinal inflammation by enhancing
RT   bacterial adhesion and invasion in colonic epithelial cells.";
RL   Gastroenterology 130:398-411(2006).
RN   [10]
RP   FUNCTION.
RX   PubMed=19414556; DOI=10.1084/jem.20081271;
RA   Lee C.G., Hartl D., Lee G.R., Koller B., Matsuura H., Da Silva C.A.,
RA   Sohn M.H., Cohn L., Homer R.J., Kozhich A.A., Humbles A., Kearley J.,
RA   Coyle A., Chupp G., Reed J., Flavell R.A., Elias J.A.;
RT   "Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in
RT   Th2 and IL-13-induced tissue responses and apoptosis.";
RL   J. Exp. Med. 206:1149-1166(2009).
RN   [11]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=20558631; DOI=10.1164/rccm.200912-1793OC;
RA   Sohn M.H., Kang M.J., Matsuura H., Bhandari V., Chen N.Y., Lee C.G.,
RA   Elias J.A.;
RT   "The chitinase-like proteins breast regression protein-39 and YKL-40
RT   regulate hyperoxia-induced acute lung injury.";
RL   Am. J. Respir. Crit. Care Med. 182:918-928(2010).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 22-383 IN COMPLEX WITH
RP   CHITIN OLIGOMERS, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-60.
RX   PubMed=12775711; DOI=10.1074/jbc.M303371200;
RA   Houston D.R., Recklies A.D., Krupa J.C., van Aalten D.M.F.;
RT   "Structure and ligand-induced conformational change of the 39-kDa
RT   glycoprotein from human articular chondrocytes.";
RL   J. Biol. Chem. 278:30206-30212(2003).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 22-383 IN COMPLEX WITH CHITIN
RP   OLIGOMERS, AND DISULFIDE BONDS.
RX   PubMed=12851408; DOI=10.1074/jbc.M303137200;
RA   Fusetti F., Pijning T., Kalk K.H., Bos E., Dijkstra B.W.;
RT   "Crystal structure and carbohydrate-binding properties of the human
RT   cartilage glycoprotein-39.";
RL   J. Biol. Chem. 278:37753-37760(2003).
RN   [14]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO ASRT7.
RX   PubMed=18403759; DOI=10.1056/NEJMoa0708801;
RA   Ober C., Tan Z., Sun Y., Possick J.D., Pan L., Nicolae R., Radford S.,
RA   Parry R.R., Heinzmann A., Deichmann K.A., Lester L.A., Gern J.E.,
RA   Lemanske R.F. Jr., Nicolae D.L., Elias J.A., Chupp G.L.;
RT   "Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma,
RT   and lung function.";
RL   N. Engl. J. Med. 358:1682-1691(2008).
CC   -!- FUNCTION: Carbohydrate-binding lectin with a preference for
CC       chitin. Has no chitinase activity. May play a role in tissue
CC       remodeling and in the capacity of cells to respond to and cope
CC       with changes in their environment. Plays a role in T-helper cell
CC       type 2 (Th2) inflammatory response and IL-13-induced inflammation,
CC       regulating allergen sensitization, inflammatory cell apoptosis,
CC       dendritic cell accumulation and M2 macrophage differentiation.
CC       Facilitates invasion of pathogenic enteric bacteria into colonic
CC       mucosa and lymphoid organs. Mediates activation of AKT1 signaling
CC       pathway and subsequent IL8 production in colonic epithelial cells.
CC       Regulates antibacterial responses in lung by contributing to
CC       macrophage bacterial killing, controlling bacterial dissemination
CC       and augmenting host tolerance. Also regulates hyperoxia-induced
CC       injury, inflammation and epithelial apoptosis in lung.
CC       {ECO:0000269|PubMed:16472595, ECO:0000269|PubMed:19414556,
CC       ECO:0000269|PubMed:20558631, ECO:0000269|PubMed:9492324}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:12775711,
CC       ECO:0000269|PubMed:12851408}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space
CC       {ECO:0000269|PubMed:9492324}. Cytoplasm {ECO:0000250}. Cytoplasm,
CC       perinuclear region {ECO:0000250}. Endoplasmic reticulum
CC       {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Present in activated macrophages, articular
CC       chondrocytes, synovial cells as well as in liver. Very low or
CC       undetectable expression in non-inflammatory colon. Undetectable in
CC       muscle tissues, lung, pancreas, mononuclear cells, or fibroblasts.
CC       {ECO:0000269|PubMed:16472595, ECO:0000269|PubMed:9492324}.
CC   -!- INDUCTION: Up-regulated in colon under several inflammatory
CC       conditions. Down-regulated by hyperoxia in bronchial epithelial
CC       cells. {ECO:0000269|PubMed:16472595, ECO:0000269|PubMed:20558631}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:12775711}.
CC   -!- DISEASE: Asthma-related traits 7 (ASRT7) [MIM:611960]: Asthma-
CC       related traits include clinical symptoms of asthma, such as
CC       coughing, wheezing, dyspnea, bronchial hyperresponsiveness as
CC       assessed by methacholine challenge test, serum IgE levels, atopy
CC       and atopic dermatitis. {ECO:0000269|PubMed:18403759}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 18 family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Although it belongs to the glycosyl hydrolase 18 family,
CC       Leu-140 is present instead of the conserved Glu which is an active
CC       site residue. Therefore this protein lacks chitinase activity.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M80927; AAA16074.1; -; mRNA.
DR   EMBL; Y08374; CAA69661.1; -; Genomic_DNA.
DR   EMBL; Y08375; CAA69661.1; JOINED; Genomic_DNA.
DR   EMBL; Y08376; CAA69661.1; JOINED; Genomic_DNA.
DR   EMBL; Y08377; CAA69661.1; JOINED; Genomic_DNA.
DR   EMBL; Y08378; CAA69661.1; JOINED; Genomic_DNA.
DR   EMBL; BT007223; AAP35887.1; -; mRNA.
DR   EMBL; AK312911; BAG35757.1; -; mRNA.
DR   EMBL; CH471067; EAW91467.1; -; Genomic_DNA.
DR   EMBL; BC008568; AAH08568.1; -; mRNA.
DR   EMBL; BC038354; AAH38354.1; -; mRNA.
DR   EMBL; BC039132; AAH39132.1; -; mRNA.
DR   CCDS; CCDS1435.1; -.
DR   PIR; A49562; A49562.
DR   RefSeq; NP_001267.2; NM_001276.2.
DR   UniGene; Hs.382202; -.
DR   UniGene; Hs.733359; -.
DR   PDB; 1HJV; X-ray; 2.75 A; A/B/C/D=22-383.
DR   PDB; 1HJW; X-ray; 2.30 A; A/B=22-383.
DR   PDB; 1HJX; X-ray; 1.85 A; A/B/C/D=22-383.
DR   PDB; 1LA7; Model; -; A=22-383.
DR   PDB; 1NWR; X-ray; 2.70 A; A/B/C/D=22-383.
DR   PDB; 1NWS; X-ray; 2.70 A; A/B/C/D=22-383.
DR   PDB; 1NWT; X-ray; 2.50 A; A/B/C/D=22-383.
DR   PDB; 1NWU; X-ray; 2.20 A; A/B/C/D=22-383.
DR   PDBsum; 1HJV; -.
DR   PDBsum; 1HJW; -.
DR   PDBsum; 1HJX; -.
DR   PDBsum; 1LA7; -.
DR   PDBsum; 1NWR; -.
DR   PDBsum; 1NWS; -.
DR   PDBsum; 1NWT; -.
DR   PDBsum; 1NWU; -.
DR   ProteinModelPortal; P36222; -.
DR   SMR; P36222; -.
DR   BioGrid; 107540; 6.
DR   STRING; 9606.ENSP00000255409; -.
DR   CAZy; GH18; Glycoside Hydrolase Family 18.
DR   iPTMnet; P36222; -.
DR   PhosphoSitePlus; P36222; -.
DR   BioMuta; CHI3L1; -.
DR   DMDM; 84028186; -.
DR   PaxDb; P36222; -.
DR   PeptideAtlas; P36222; -.
DR   PRIDE; P36222; -.
DR   DNASU; 1116; -.
DR   Ensembl; ENST00000255409; ENSP00000255409; ENSG00000133048.
DR   GeneID; 1116; -.
DR   KEGG; hsa:1116; -.
DR   UCSC; uc001gzi.3; human.
DR   CTD; 1116; -.
DR   DisGeNET; 1116; -.
DR   GeneCards; CHI3L1; -.
DR   HGNC; HGNC:1932; CHI3L1.
DR   HPA; HPA072269; -.
DR   MalaCards; CHI3L1; -.
DR   MIM; 601525; gene.
DR   MIM; 611960; phenotype.
DR   neXtProt; NX_P36222; -.
DR   OpenTargets; ENSG00000133048; -.
DR   PharmGKB; PA26463; -.
DR   eggNOG; KOG2806; Eukaryota.
DR   eggNOG; COG3325; LUCA.
DR   GeneTree; ENSGT00550000074323; -.
DR   HOGENOM; HOG000111109; -.
DR   HOVERGEN; HBG011684; -.
DR   InParanoid; P36222; -.
DR   KO; K17523; -.
DR   OMA; IAKISQH; -.
DR   OrthoDB; EOG091G014W; -.
DR   PhylomeDB; P36222; -.
DR   TreeFam; TF315610; -.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   SIGNOR; P36222; -.
DR   ChiTaRS; CHI3L1; human.
DR   EvolutionaryTrace; P36222; -.
DR   GeneWiki; CHI3L1; -.
DR   GenomeRNAi; 1116; -.
DR   PRO; PR:P36222; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000133048; -.
DR   CleanEx; HS_CHI3L1; -.
DR   ExpressionAtlas; P36222; baseline and differential.
DR   Genevisible; P36222; HS.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005578; C:proteinaceous extracellular matrix; NAS:UniProtKB.
DR   GO; GO:0035580; C:specific granule lumen; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0008061; F:chitin binding; IDA:UniProtKB.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; NAS:UniProtKB.
DR   GO; GO:0007250; P:activation of NF-kappaB-inducing kinase activity; ISS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0051216; P:cartilage development; NAS:UniProtKB.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; ISS:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEP:UniProtKB.
DR   GO; GO:0072606; P:interleukin-8 secretion; ISS:UniProtKB.
DR   GO; GO:0030324; P:lung development; IMP:UniProtKB.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:UniProtKB.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; IMP:UniProtKB.
DR   GO; GO:0070555; P:response to interleukin-1; IEP:UniProtKB.
DR   GO; GO:0070741; P:response to interleukin-6; IEP:UniProtKB.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0034612; P:response to tumor necrosis factor; IEP:UniProtKB.
DR   InterPro; IPR028538; CHI3L1.
DR   InterPro; IPR011583; Chitinase_II.
DR   InterPro; IPR029070; Chitinase_insertion.
DR   InterPro; IPR001223; Glyco_hydro18_cat.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR11177:SF249; PTHR11177:SF249; 1.
DR   Pfam; PF00704; Glyco_hydro_18; 1.
DR   SMART; SM00636; Glyco_18; 1.
DR   SUPFAM; SSF51445; SSF51445; 2.
DR   SUPFAM; SSF54556; SSF54556; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Antimicrobial; Apoptosis; Asthma; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Inflammatory response; Lectin;
KW   Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     21       {ECO:0000269|PubMed:2375755,
FT                                ECO:0000269|PubMed:9492324}.
FT   CHAIN        22    383       Chitinase-3-like protein 1.
FT                                /FTId=PRO_0000011965.
FT   REGION       70     71       Chitooligosaccharide binding.
FT   REGION       97    100       Chitooligosaccharide binding.
FT   REGION      204    207       Chitooligosaccharide binding.
FT   REGION      324    338       Important for AKT1 activation and IL8
FT                                production. {ECO:0000250}.
FT   BINDING     141    141       Chitooligosaccharide.
FT   BINDING     263    263       Chitooligosaccharide.
FT   BINDING     352    352       Chitooligosaccharide.
FT   CARBOHYD     60     60       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12775711}.
FT   DISULFID     26     51
FT   DISULFID    300    364
FT   VARIANT     145    145       R -> G (in dbSNP:rs880633).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_019838.
FT   VARIANT     311    311       I -> T (in dbSNP:rs1049407).
FT                                {ECO:0000269|PubMed:8245017,
FT                                ECO:0000269|PubMed:9244440}.
FT                                /FTId=VAR_019839.
FT   STRAND       23     29       {ECO:0000244|PDB:1HJX}.
FT   HELIX        30     34       {ECO:0000244|PDB:1HJX}.
FT   HELIX        37     39       {ECO:0000244|PDB:1HJX}.
FT   HELIX        43     45       {ECO:0000244|PDB:1HJX}.
FT   TURN         48     50       {ECO:0000244|PDB:1HJX}.
FT   STRAND       52     62       {ECO:0000244|PDB:1HJX}.
FT   STRAND       65     67       {ECO:0000244|PDB:1HJX}.
FT   HELIX        73     82       {ECO:0000244|PDB:1HJX}.
FT   HELIX        83     85       {ECO:0000244|PDB:1NWU}.
FT   STRAND       91     97       {ECO:0000244|PDB:1HJX}.
FT   TURN         99    101       {ECO:0000244|PDB:1HJX}.
FT   HELIX       103    111       {ECO:0000244|PDB:1HJX}.
FT   HELIX       113    130       {ECO:0000244|PDB:1HJX}.
FT   STRAND      133    138       {ECO:0000244|PDB:1HJX}.
FT   HELIX       144    146       {ECO:0000244|PDB:1NWU}.
FT   HELIX       147    165       {ECO:0000244|PDB:1HJX}.
FT   TURN        166    168       {ECO:0000244|PDB:1HJX}.
FT   STRAND      173    179       {ECO:0000244|PDB:1HJX}.
FT   HELIX       182    188       {ECO:0000244|PDB:1HJX}.
FT   HELIX       191    197       {ECO:0000244|PDB:1HJX}.
FT   STRAND      199    204       {ECO:0000244|PDB:1HJX}.
FT   HELIX       211    213       {ECO:0000244|PDB:1NWU}.
FT   HELIX       227    229       {ECO:0000244|PDB:1HJX}.
FT   STRAND      233    236       {ECO:0000244|PDB:1NWU}.
FT   HELIX       237    247       {ECO:0000244|PDB:1HJX}.
FT   HELIX       251    253       {ECO:0000244|PDB:1HJX}.
FT   STRAND      254    270       {ECO:0000244|PDB:1HJX}.
FT   STRAND      277    281       {ECO:0000244|PDB:1HJX}.
FT   TURN        286    288       {ECO:0000244|PDB:1HJX}.
FT   STRAND      293    295       {ECO:0000244|PDB:1HJX}.
FT   HELIX       296    302       {ECO:0000244|PDB:1HJX}.
FT   TURN        303    305       {ECO:0000244|PDB:1HJX}.
FT   STRAND      307    310       {ECO:0000244|PDB:1HJX}.
FT   TURN        312    314       {ECO:0000244|PDB:1HJX}.
FT   STRAND      317    321       {ECO:0000244|PDB:1HJX}.
FT   STRAND      324    327       {ECO:0000244|PDB:1HJX}.
FT   HELIX       331    343       {ECO:0000244|PDB:1HJX}.
FT   STRAND      347    352       {ECO:0000244|PDB:1HJX}.
FT   HELIX       354    356       {ECO:0000244|PDB:1HJX}.
FT   STRAND      359    361       {ECO:0000244|PDB:1HJX}.
FT   STRAND      363    366       {ECO:0000244|PDB:1HJX}.
FT   HELIX       371    381       {ECO:0000244|PDB:1HJX}.
SQ   SEQUENCE   383 AA;  42625 MW;  6C9EF133BDC7C2D1 CRC64;
     MGVKASQTGF VVLVLLQCCS AYKLVCYYTS WSQYREGDGS CFPDALDRFL CTHIIYSFAN
     ISNDHIDTWE WNDVTLYGML NTLKNRNPNL KTLLSVGGWN FGSQRFSKIA SNTQSRRTFI
     KSVPPFLRTH GFDGLDLAWL YPGRRDKQHF TTLIKEMKAE FIKEAQPGKK QLLLSAALSA
     GKVTIDSSYD IAKISQHLDF ISIMTYDFHG AWRGTTGHHS PLFRGQEDAS PDRFSNTDYA
     VGYMLRLGAP ASKLVMGIPT FGRSFTLASS ETGVGAPISG PGIPGRFTKE AGTLAYYEIC
     DFLRGATVHR ILGQQVPYAT KGNQWVGYDD QESVKSKVQY LKDRQLAGAM VWALDLDDFQ
     GSFCGQDLRF PLTNAIKDAL AAT
//
